Newlink Genetics (NLNK) Posts Q3 Loss of 28c

Go back to Newlink Genetics (NLNK) Posts Q3 Loss of 28c

Baird Says Time is Right to Own NewLink Genetics (NLNK)

October 31, 2012 1:49 PM EDT

Baird reiterated an Outperform rating on NewLink Genetics (NASDAQ: NLNK) and raised its price target to $20.00 (from $17.00).

"Though the quarterly print was uneventful, we continue to like NLNK for its significant pipeline potential, with first HyperAcute Pancreas Phase III interim look in... More